Valuation: Precipio, Inc.

Market Cap 43.4M 38M 35.08M 32.76M 61.66M 4.1B 63.07M 422M 163M 2.02B 163M 159M 7.03B P/E 2024
-1.89x
P/E 2025 -102x
Enterprise Value 44.4M 38.88M 35.89M 33.51M 63.09M 4.2B 64.53M 432M 167M 2.07B 167M 163M 7.19B EV / Sales 2024
0.44x
EV / Sales 2025 1.72x
Free-Float
87.41%
Yield 2024 *
-
Yield 2025 -
1 day+4.16%
1 week+4.45%
Current month+6.49%
1 month+6.49%
3 months-6.51%
6 months+4.75%
Current year+5.66%
1 week 22
Extreme 22
24.4
1 month 21.37
Extreme 21.3715
24.4
Current year 19.52
Extreme 19.52
33.63
1 year 10.92
Extreme 10.92
33.63
3 years 3.9
Extreme 3.9
33.63
5 years 3.9
Extreme 3.9
83.4
10 years 3.9
Extreme 3.9
8,448.01
Manager TitleAgeSince
Chief Executive Officer 54 2017-06-27
Director of Finance/CFO 59 2022-03-20
Chief Tech/Sci/R&D Officer 42 2017-05-31
Director TitleAgeSince
Director/Board Member 54 2017-06-27
Director/Board Member 78 2017-09-25
Director/Board Member 67 2017-11-07
Date Insider Type Main position Quantity % Market Cap.
May. 20Sell

Chairman

-900 0.0505%
May. 19Sell

Chairman

-2,534 0.1421%
Apr. 14Free

Director

93 0.0053%
Change 5-day change 1-year change 3-year change Capi.($)
+4.16%+4.45%+123.41%+247.65% 43.4M
-0.04%+5.07%+1.08%-26.28% 16.13B
+4.39%-3.44%+24.34%+70.87% 1.51B
-0.26%-3.42%-32.48%+28.68% 1.09B
+32.20%+47.37%-36.85%-77.62% 1.24B
+3.30%-7.72%-24.00%-53.25% 629M
+5.86%+2.42%-35.56%-56.56% 594M
-3.01%-4.04%+16.32%-56.98% 421M
-0.48%-1.27%-55.18%-60.37% 379M
-0.44%-0.29%-25.28%-26.49% 332M
Average +4.92%+3.20%-4.42%-1.03% 2.24B
Weighted average by Cap. +3.01%+5.36%-3.60%-22.10%

Financials

2024 2025
Net sales 18.53M 16.23M 14.98M 13.99M 26.33M 1.75B 26.93M 180M 69.59M 864M 69.6M 68.07M 3B 24.05M 21.06M 19.44M 18.15M 34.17M 2.27B 34.95M 234M 90.31M 1.12B 90.31M 88.33M 3.89B
Net income -4.29M -3.76M -3.47M -3.24M -6.1M -406M -6.23M -41.73M -16.11M -200M -16.11M -15.76M -695M -363K -318K -293K -274K -516K -34.32M -528K -3.53M -1.36M -16.93M -1.36M -1.33M -58.78M
Net Debt -136K -119K -110K -103K -193K -12.86M -198K -1.32M -511K -6.34M -511K -500K -22.02M 1M 877K 810K 756K 1.42M 94.73M 1.46M 9.75M 3.76M 46.74M 3.76M 3.68M 162M
Logo Precipio, Inc.
Precipio, Inc. is a healthcare biotechnology company that is focused on cancer diagnostics. The Company’s technologies include HemeScreen and IV-Cell. The HemeScreen panels test for the presence of various mutations. In developing HemeScreen, it focused on improving the economics of providing blood cancer diagnostic tests and reducing laboratory technician time consumed in the testing process. Its technology enables testing to be completed in one rapid scanning process. IV-Cell is a cell culture media that addresses the problem of diagnostic mistakes through the process of selective culturing. IV-Cell is a universal media that enables simultaneous culturing of all four hematopoietic cell lineages. Its product category includes Molecular Kits and IV-Cell Cytogenetics Media. The Molecular Kits include Quantitative MPN Panel, ABL1 Resistance Panel, and others. The Company’s laboratory and research and development (R&D) facilities are located in New Haven, Connecticut and Omaha, Nebraska.
Employees
66
Date Price Change Volume
26-06-29 $24.28 +4.16% 5,250
26-06-26 $23.31 +4.04% 54,316
26-06-25 $22.41 -2.42% 18,353
26-06-24 $22.96 -1.03% 26,364
26-06-23 $23.20 -0.19% 74,327
  1. Stock Market
  2. Stocks
  3. PRPO Stock